These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31672338)

  • 1. Cannabis in psychiatric disorders: the cart before the horse?
    D'Souza DC
    Lancet Psychiatry; 2019 Dec; 6(12):968-969. PubMed ID: 31672338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cannabis, Cannabinoids and Cannabis Use Disorders].
    Hoch E; Preuss UW
    Fortschr Neurol Psychiatr; 2019 Dec; 87(12):714-728. PubMed ID: 31847034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position statement of the Brazilian Psychiatric Association on the use of cannabis in psychiatric treatment.
    da Silva AG; Baldaçara L
    Braz J Psychiatry; 2022 Aug; 44(6):572-573. PubMed ID: 35870135
    [No Abstract]   [Full Text] [Related]  

  • 4. Circumspectives: Cannabis and Psychiatric Illness: Blunt Thoughts.
    Heilig M; Carlezon WA
    Neuropsychopharmacology; 2016 Jan; 41(2):391-2. PubMed ID: 26555278
    [No Abstract]   [Full Text] [Related]  

  • 5. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond the cannabis controversy into the world of the cannabinoids.
    Budney AJ; Lile JA
    Int Rev Psychiatry; 2009 Apr; 21(2):91-5. PubMed ID: 19367502
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in cannabis use, is cannabis use disorder a valid diagnosis?
    Hamilton I; Monaghan M
    Int J Drug Policy; 2019 Jul; 69():53-54. PubMed ID: 31082634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychiatric complications of cannabis use].
    Bulacia AV
    Vertex; 2016 Nov; XXVII(130):474-477. PubMed ID: 28898309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.
    Shalit N; Barzilay R; Shoval G; Shlosberg D; Mor N; Zweigenhaft N; Weizman A; Krivoy A
    J Clin Psychiatry; 2016 Aug; 77(8):e989-95. PubMed ID: 27379411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabis abuse in patients with psychiatric disorders: an update to old evidence].
    Diehl A; Cordeiro DC; Laranjeira R
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S41-5. PubMed ID: 20512269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical marijuana laws, substance use treatment admissions and the ecological fallacy.
    Caputi TL
    Addiction; 2020 Jan; 115(1):188-189. PubMed ID: 31724211
    [No Abstract]   [Full Text] [Related]  

  • 12. Cannabinoids and hallucinogens for headache.
    McGeeney BE
    Headache; 2013 Mar; 53(3):447-58. PubMed ID: 23278122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study.
    Aharonovich E; Liu X; Samet S; Nunes E; Waxman R; Hasin D
    Am J Psychiatry; 2005 Aug; 162(8):1507-14. PubMed ID: 16055773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on Salloum et al. (2018): Rethinking adolescent cannabis use and risk perception.
    Freeman TP; Wilson J; Mackie C
    Addiction; 2018 Jun; 113(6):1086-1087. PubMed ID: 29732700
    [No Abstract]   [Full Text] [Related]  

  • 15. The adverse health effects of chronic cannabis use.
    Hall W; Degenhardt L
    Drug Test Anal; 2014; 6(1-2):39-45. PubMed ID: 23836598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consideration of use opportunities, novel products, and user modes in cannabis monitoring, research, and policy: a response to the commentary.
    Burdzovic Andreas J; Bretteville-Jensen AL
    Addiction; 2018 Mar; 113(3):575-576. PubMed ID: 29282781
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence shows that cannabis has fewer relative harms than opioids.
    Lake S; Socías ME; Milloy MJ
    CMAJ; 2020 Feb; 192(7):E166-E167. PubMed ID: 32071110
    [No Abstract]   [Full Text] [Related]  

  • 18. Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.
    Parrott AC; Gouzoulis-Meyfrank E; Rodgers J; Solowij N
    J Psychopharmacol; 2004 Dec; 18(4):572-5. PubMed ID: 15582925
    [No Abstract]   [Full Text] [Related]  

  • 19. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic cannabinoids: undesirable alternatives to natural marijuana.
    Palamar JJ; Barratt MJ
    Am J Drug Alcohol Abuse; 2016 Jul; 42(4):371-3. PubMed ID: 27064929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.